Abstract
A new clonal strain of Candida auris is an emerging etiologic agent of fungemia in Delhi, India. In 12 patients in 2 hospitals, it was resistant to fluconazole and genotypically distinct from isolates from South Korea and Japan, as revealed by M13 and amplified fragment length polymorphism typing.
Keywords:
AFLP; Candida auris; India; M13 fingerprinting; antifungal susceptibility; fungemia; fungi; parasitic diseases.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Antifungal Agents / pharmacology
-
Antifungal Agents / therapeutic use
-
Candida / classification
-
Candida / genetics*
-
Candida / isolation & purification
-
Candidiasis / drug therapy
-
Candidiasis / microbiology*
-
Candidiasis / mortality
-
Child
-
DNA, Fungal / genetics
-
DNA, Ribosomal Spacer / genetics
-
Drug Resistance, Fungal
-
Female
-
Fluconazole / pharmacology
-
Fluconazole / therapeutic use
-
Fungemia / drug therapy
-
Fungemia / microbiology*
-
Fungemia / mortality
-
Humans
-
India
-
Infant
-
Infant, Newborn
-
Male
-
Microbial Sensitivity Tests
-
Middle Aged
-
Multilocus Sequence Typing
-
Phylogeny
-
Polymorphism, Restriction Fragment Length
-
Treatment Outcome
Substances
-
Antifungal Agents
-
DNA, Fungal
-
DNA, Ribosomal Spacer
-
Fluconazole